Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmapress Oy
OY
Active
Y-tunnus 1089493-3
Elimäenkatu 5, 00510
Helsinki
Publishing of journals and periodicals
·
NACE 5813
Est. 1997 · 29 years old
5 employees
Share
Finland
/
Companies
/
Publishing of journals and periodicals
/
Pharmapress Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
1 254
1 399
1 341
1 374
1 175
Staff expenses
−251
−249
−276
−258
−317
EBITDA
108
183
133
167
176
Depreciation & amort.
−27
−19
−6
−3
−0
EBIT
81
164
128
164
176
Net financials
0
10
0
0
−0
Profit before tax
81
174
128
164
176
Tax
16
35
26
33
28
Net profit
65
139
102
132
148
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
545
659
699
651
653
Equity
469
543
504
533
541
Long-term debt
0
0
0
—
—
Short-term debt
76
116
195
119
111
Total debt
76
116
195
119
111
Financial ratios
5-year trend
EBITDA margin
8,6 %
This company
15,8 %
Market median
This company
Market median
46% below market
2021
2025
Equity ratio
86,0 %
This company
38,2 %
Market median
This company
Market median
125% above market
2021
2025
Return on equity
13,8 %
This company
18,4 %
Market median
This company
Market median
25% below market
2021
2025
Net profit margin
5,2 %
This company
8,1 %
Market median
This company
Market median
36% below market
2021
2025
Asset turnover
2,30×
This company
1,12×
Market median
This company
Market median
105% above market
2021
2025
Debt / equity
0,16×
This company
0,62×
Market median
This company
Market median
74% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmapress Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
